Do cephalosporins potentiate or antagonize aminoglycoside nephrotoxicity?
D000617:Aminoglycosides / Q000009:adverse effects / Q000037:antagonists & inhibitors; D000818:Animals; D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000037:antagonists & inhibitors; D002511:Cephalosporins / Q000009:adverse effects* / Q000627:therapeutic use; D004357:Drug Synergism; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced* / Q000517:prevention & control
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D002511:Cephalosporins